137 related articles for article (PubMed ID: 11520140)
1. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies.
Mundt AJ; Roeske JC; Lujan AE; Yamada SD; Waggoner SE; Fleming G; Rotmensch J
Gynecol Oncol; 2001 Sep; 82(3):456-63. PubMed ID: 11520140
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies.
Mundt AJ; Lujan AE; Rotmensch J; Waggoner SE; Yamada SD; Fleming G; Roeske JC
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1330-7. PubMed ID: 11955746
[TBL] [Abstract][Full Text] [Related]
3. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.
Mundt AJ; Mell LK; Roeske JC
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1354-60. PubMed ID: 12873680
[TBL] [Abstract][Full Text] [Related]
4. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
Brixey CJ; Roeske JC; Lujan AE; Yamada SD; Rotmensch J; Mundt AJ
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1388-96. PubMed ID: 12459361
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies.
Roeske JC; Lujan A; Rotmensch J; Waggoner SE; Yamada D; Mundt AJ
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1613-21. PubMed ID: 11121668
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy.
Lujan AE; Mundt AJ; Yamada SD; Rotmensch J; Roeske JC
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):516-21. PubMed ID: 12957265
[TBL] [Abstract][Full Text] [Related]
7. The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer.
Liu YM; Shiau CY; Lee ML; Huang PI; Hsieh CM; Chen PH; Lin YH; Wang LW; Yen SH
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1113-23. PubMed ID: 17197126
[TBL] [Abstract][Full Text] [Related]
8. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy.
Roeske JC; Bonta D; Mell LK; Lujan AE; Mundt AJ
Radiother Oncol; 2003 Nov; 69(2):201-7. PubMed ID: 14643959
[TBL] [Abstract][Full Text] [Related]
9. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.
Ashman JB; Zelefsky MJ; Hunt MS; Leibel SA; Fuks Z
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):765-71. PubMed ID: 15913914
[TBL] [Abstract][Full Text] [Related]
10. A dosimetric planning study comparing intensity-modulated radiotherapy with four-field conformal pelvic radiotherapy for the definitive treatment of cervical carcinoma.
Forrest J; Presutti J; Davidson M; Hamilton P; Kiss A; Thomas G
Clin Oncol (R Coll Radiol); 2012 May; 24(4):e63-70. PubMed ID: 21752614
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids.
Baek JG; Kim EC; Kim SK; Jang H
Br J Radiol; 2015; 88(1056):20150223. PubMed ID: 26395671
[TBL] [Abstract][Full Text] [Related]
13. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.
Lin LL; Kirk M; Scholey J; Taku N; Kiely JB; White B; Both S
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):181-189. PubMed ID: 26372435
[TBL] [Abstract][Full Text] [Related]
14. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms.
Heron DE; Gerszten K; Selvaraj RN; King GC; Sonnik D; Gallion H; Comerci J; Edwards RP; Wu A; Andrade RS; Kalnicki S
Gynecol Oncol; 2003 Oct; 91(1):39-45. PubMed ID: 14529660
[TBL] [Abstract][Full Text] [Related]
15. A novel conformal arc technique for postoperative whole pelvic radiotherapy for endometrial cancer.
Yang R; Jiang W; Wang J
Int J Gynecol Cancer; 2009 Dec; 19(9):1574-9. PubMed ID: 19955940
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
[TBL] [Abstract][Full Text] [Related]
17. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?
Adli M; Mayr NA; Kaiser HS; Skwarchuk MW; Meeks SL; Mardirossian G; Paulino AC; Montebello JF; Gaston RC; Sorosky JI; Buatti JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):230-8. PubMed ID: 12909238
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
19. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 3D conformal radiation therapy and intensity-modulated radiation therapy in patients with endometrial cancer: efficacy, safety and prognostic analysis.
Ta MH; Schernberg A; Giraud P; Monnier L; Darai É; Bendifallah S; Schlienger M; Touboul E; Orthuon A; Challand T; Huguet F; Rivin Del Campo E
Acta Oncol; 2019 Aug; 58(8):1127-1134. PubMed ID: 31017032
[No Abstract] [Full Text] [Related]
[Next] [New Search]
